Brain and spinal cord tumors
Conditions
Interventions
1. 11C will be prepared with the cyclotron at Tohoku University Hospital. Methionine will be synthesized and examined in the hot laboratory. 2. Synthesized methionine will be given intravenously to t
Sponsors
Department of Neurosurgery, Tohoku University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Cases diagnosed as brain or spinal cord tumors with other methodologies such as CT and /or MRI. Cases with brain or spinal cord tumors with suspected recurrence after treatment. 2) Patients with operable systemic conditions. 3) Though with consciousness disturbances and/or neurological deficits, patients with operable systemic conditions will be eligible. 4) Informed consent taken from the patient. In case it is difficult to get the signature of patient due to neurological deficits, representative person may sign as long as patient is able to understand and give his approval.
Exclusion criteria
Exclusion criteria: 1) Patients without brain or spinal cord lesions. 2) Patients whose systemic condition not able to tolerate the surgical intervention. 3) Patients unable to give the approval. 4) Women in pregnancy or breast feeding women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic accuracy compared to the histological diagnosis. | — |
Countries
Japan
Contacts
Public ContactRyuta Saito
Tohoku University Graduate School of Medicine Department of Neurosurgery
Outcome results
None listed